Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )
PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment
1,000
Participants
Timeline
Start Date
April 15, 2023
Primary Completion Date
May 30, 2024
Study Completion Date
December 1, 2025
Conditions
Acute Pain
Interventions
DRUG
Ketamine
giving ketamine intranasal
Trial Locations (1)
5000
RECRUITING
university of Monastir, Monastir
All Listed Sponsors
lead
University of Monastir
OTHER
NCT05229055 - Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK ) | Biotech Hunter | Biotech Hunter